PIO THERAPEUTICS
Pio Therapeutics focuses on the development of novel, innovative, and targeted cancer therapies to improve patient outcomes. It helps to boost endogenous anti-tumor immunity, with an emphasis on accelerating the development of PIO-001, a first-in-class agonist antibody that solves existing immunotherapy clinical problems, such as enhancing the pace and quality of responses in a variety of solid tumors. It is launched in 2021 and founded by BioCurate and Monash University.
PIO THERAPEUTICS
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2021-01-01
Address:
Parkville, New South Wales, Australia
Country:
Australia
Website Url:
http://www.piotx.com
Status:
Active
Contact:
61394488443
Email Addresses:
[email protected]
Technology used in webpage:
Euro Gravity Forms
Similar Organizations
Cytori Therapeutics
Cytori Therapeutics engages in the development of autologous cell therapies.
D2M Biotherapeutics
D2M Biotherapeutics focuses on the development of novel immunotherapeutics.
Lineberry Research Associates
Lineberry Research Associates provide strategic drug development and innovative therapies to the patients.
WAIMR
WAIMR operates a research consortium in the development of cancer, diabetes and heart disease treatments.
Current Employees Featured
Official Site Inspections
http://www.piotx.com Semrush global rank: 9.08 M Semrush visits lastest month: 218
- Host name: 28.139.99.139.static.promptwebhosting.com.au
- IP address: 139.99.139.28
- Location: Sydney Australia
- Latitude: -33.8591
- Longitude: 151.2002
- Timezone: Australia/Sydney
- Postal: 2000
